875 related articles for article (PubMed ID: 28798201)
1. Remote ischemic preconditioning does not prevent acute mountain sickness after rapid ascent to 3,450 m.
Berger MM; Macholz F; Lehmann L; Dankl D; Hochreiter M; Bacher B; Bärtsch P; Mairbäurl H
J Appl Physiol (1985); 2017 Nov; 123(5):1228-1234. PubMed ID: 28798201
[TBL] [Abstract][Full Text] [Related]
2. Repeated remote ischaemic preconditioning can prevent acute mountain sickness after rapid ascent to a high altitude.
Wang Z; Lv B; Zhang L; Gao R; Zhao W; Wang L; Min Z; Mi Z; Song Y; Zhang J; Yu Y; Ji X; Li J; Wu L
Eur J Sport Sci; 2022 Aug; 22(8):1304-1314. PubMed ID: 33977839
[TBL] [Abstract][Full Text] [Related]
3. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
4. Effects of acetazolamide combined with remote ischemic preconditioning on risk of acute mountain sickness: a randomized clinical trial.
Liu M; Jiao X; Li R; Li J; Wang L; Wang L; Wang Y; Lv C; Huang D; Wei R; Wang L; Ji X; Guo X
BMC Med; 2024 Jan; 22(1):4. PubMed ID: 38166913
[TBL] [Abstract][Full Text] [Related]
5. Remote ischemic preconditioning for prevention of high-altitude diseases: fact or fiction?
Berger MM; Macholz F; Mairbäurl H; Bärtsch P
J Appl Physiol (1985); 2015 Nov; 119(10):1143-51. PubMed ID: 26089545
[TBL] [Abstract][Full Text] [Related]
6. Remote ischemic preconditioning delays the onset of acute mountain sickness in normobaric hypoxia.
Berger MM; Köhne H; Hotz L; Hammer M; Schommer K; Bärtsch P; Mairbäurl H
Physiol Rep; 2015 Mar; 3(3):. PubMed ID: 25742960
[TBL] [Abstract][Full Text] [Related]
7. Remote ischemic preconditioning improves spatial memory and sleep of young males during acute high-altitude exposure.
Wu Y; Zhou S; Li Y; Huang P; Zhong Z; Dong H; Tian H; Jiang S; Xie J; Li P
Travel Med Infect Dis; 2023; 53():102576. PubMed ID: 37068619
[TBL] [Abstract][Full Text] [Related]
8. One session of remote ischemic preconditioning does not improve vascular function in acute normobaric and chronic hypobaric hypoxia.
Rieger MG; Hoiland RL; Tremblay JC; Stembridge M; Bain AR; Flück D; Subedi P; Anholm JD; Ainslie PN
Exp Physiol; 2017 Sep; 102(9):1143-1157. PubMed ID: 28699679
[TBL] [Abstract][Full Text] [Related]
9. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
Grissom CK; Richer LD; Elstad MR
Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
[TBL] [Abstract][Full Text] [Related]
10. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
[TBL] [Abstract][Full Text] [Related]
11. Dietary nitrate supplementation increases acute mountain sickness severity and sense of effort during hypoxic exercise.
Rossetti GMK; Macdonald JH; Wylie LJ; Little SJ; Newton V; Wood B; Hawkins KA; Beddoe R; Davies HE; Oliver SJ
J Appl Physiol (1985); 2017 Oct; 123(4):983-992. PubMed ID: 28684588
[TBL] [Abstract][Full Text] [Related]
12. Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m.
Schommer K; Wiesegart N; Menold E; Haas U; Lahr K; Buhl H; Bärtsch P; Dehnert C
High Alt Med Biol; 2010; 11(1):19-25. PubMed ID: 20367484
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial.
Bates MG; Thompson AA; Baillie JK; Sutherland AI; Irving JB; Hirani N; Webb DJ
High Alt Med Biol; 2011; 12(3):207-14. PubMed ID: 21962063
[TBL] [Abstract][Full Text] [Related]
14. Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review.
Meier D; Collet TH; Locatelli I; Cornuz J; Kayser B; Simel DL; Sartori C
JAMA; 2017 Nov; 318(18):1810-1819. PubMed ID: 29136449
[TBL] [Abstract][Full Text] [Related]
15. Nifedipine does not prevent acute mountain sickness.
Hohenhaus E; Niroomand F; Goerre S; Vock P; Oelz O; Bärtsch P
Am J Respir Crit Care Med; 1994 Sep; 150(3):857-60. PubMed ID: 8087361
[TBL] [Abstract][Full Text] [Related]
16. High altitude illness in pilgrims after rapid ascent to 4380 M.
Zafren K; Pun M; Regmi N; Bashyal G; Acharya B; Gautam S; Jamarkattel S; Lamichhane SR; Acharya S; Basnyat B
Travel Med Infect Dis; 2017; 16():31-34. PubMed ID: 28285976
[TBL] [Abstract][Full Text] [Related]
17. Ischemic preconditioning improves oxygen saturation and attenuates hypoxic pulmonary vasoconstriction at high altitude.
Foster GP; Giri PC; Rogers DM; Larson SR; Anholm JD
High Alt Med Biol; 2014 Jun; 15(2):155-61. PubMed ID: 24949710
[TBL] [Abstract][Full Text] [Related]
18. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial.
Maggiorini M; Brunner-La Rocca HP; Peth S; Fischler M; Böhm T; Bernheim A; Kiencke S; Bloch KE; Dehnert C; Naeije R; Lehmann T; Bärtsch P; Mairbäurl H
Ann Intern Med; 2006 Oct; 145(7):497-506. PubMed ID: 17015867
[TBL] [Abstract][Full Text] [Related]
19. Endurance Athletes Are at Increased Risk for Early Acute Mountain Sickness at 3450 m.
Sareban M; Schiefer LM; Macholz F; Schäfer L; Zangl Q; Inama F; Reich B; Mayr B; Schmidt P; Hartl A; Bärtsch P; Niebauer J; Treff G; Berger MM
Med Sci Sports Exerc; 2020 May; 52(5):1109-1115. PubMed ID: 31876668
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of residence at moderate versus low altitude on reducing acute mountain sickness in men following rapid ascent to 4300 m.
Staab JE; Beidleman BA; Muza SR; Fulco CS; Rock PB; Cymerman A
High Alt Med Biol; 2013 Mar; 14(1):13-8. PubMed ID: 23537255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
